Chapter 12 Sphringolipids: metabolism and cell signalling

New Comprehensive Biochemistry

Volumn 31, Issue C, 1996, Pages 309-339

  Merill Jr , Alfred H ^a   Sweeley, Charles C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956679613     PISSN: 01677306     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0167-7306(08)60519-0     Document Type: Chapter

References (29)

1. Thudichum J.L.W. A Treatise on the Chemical Constitution of Brain (1884), Bailliere, Tindall, and Cox, London
2. Sweeley C.C., and Siddiqui B. Chemistry of mammalian glycolipids. In: Horowitz M.I., and Pigman W. (Eds). The Glycoproteins 1 (1977), Academic Press, New York 459-540
3. Hakomori S. Chemistry of glycosphingolipids. In: Kanfer J.N., and Hakomori S. (Eds). Sphingolipid Biochemistry (1983), Plenum, New York 1-164
4. Stults C.L.M., Sweeley C.C., and Macher B.A. Glycosphingolipids: structure, biological source and properties. Methods Enzymol. 50 (1989) 167-214
5. Barenholz Y., and Thompson T.E. Sphingomyelins in bilayers and biological membranes, Biochim. Biophys. Acta 604 (1980) 129-158
6. Merrill Jr. A.H., and Jones D.D. An update of the enzymology and regulation of sphingomye-lin metabolism. Biochim. Biophys. Acta 1044 (1990) 1-12
7. Brady R.O., and Barton N.W. Enzyme replacement therapy for Gaucher disease: critical investigations beyond demonstration of clinical efficacy. Biochem. Med. Metab. Biol. 52 (1994) 1-9
8. Bell R.M., Hannun Y.A., and Merrill Jr. A.H. Advances in Lipid Research: Sphingolipids Part A: Functions and Breakdown Products 25 (1993), Academic Press, Orlando, FL 339
9. Bell R.M., Hannun Y.A., and Merrill Jr. A.H. Advances in Lipid Research: Sphingolipids Part B: Regulation and Function of Metabolism 26 (1993), Academic Press, Orlando, FL 384
10. Hoekstra D. Current Topics in Membranes: Cell Lipids 40 (1994), Academic Press, San Diego, CA. 638
11. Lester R.L., Wells G.B., Oxford G., and Dickson R.C. Mutant strains of Saccharomyces cerevisae lacking sphingolipids synthesize novel inositol glycerophospholipids that mimic sphingolipid structures. J. Biol. Chem. 268 (1993) 845-856
12. Hanada K., Nishijima M., Kiso M., Hasegawa A., Fujita S., Ogawa T., and Akamatsu Y. Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis with exogenous sphingolipids, J. Biol. Chem. 267 (1992) 23527-23533
13. IUPAC-IUB Recommendations on Glycolipid Nomenclature. Lipids 12 (1977) 455-468
14. Bio-chem. J. 171 (1975) 21-35
15. Karlsson K.-A. On the chemistry and occurrence of sphingolipid long-chain bases. Lipids 5 (1970) 6-43
16. Wiegandt H. Glycolipids (1985), Elsevier, Amsterdam
17. Yu R.K., and Saito M. Structure and localization of gangliosides. In: Margolis R.U., and Margolis R.K. (Eds). Neurobiology of Glycoconjugates (1989), Plenum, New York 1-42
18. Wiegandt H. The chemical constitution of gangliosides of the vertebrate nervous system. Behav. Brain. Res. 66 (1995) 85-97
19. Sonnino S., Cantu L., Corti M., Acquotti D., and Venerando B. Aggregative properties of gangliosides in solution, Chem. Phys. Lipids 71 (1994) 21-45
20. Vos J.P., Lopes-Cardozo M., and Gadella B.M. Metabolic and functional aspects of sulfogalactolipids, Biochim. Biophys. Acta 1211 (1994) 125-149
21. Miyake Y., Kozutsumi Y., Nakamura S., Fujita T., and Kawasaki T. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin, Biochem. Biophys. Res. Commun. 211 (1995) 396-403
22. van Echten G., and Sandhoff K. Ganglioside metabolism: enzymology, topology, and regulation. J. Biol. Chem. 268 (1993) 5341-5344
23. Neufeld E.F. Natural history and inherited disorders of a lysosomal enzyme, β-hexosaminidase, J. Biol. Chem. 264 (1989) 10927-10930
24. Desnick R.J., Ioannou Y.A., and Eng C.M. α-Galactosidase A deficiency: Fabry disease. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease 7th edn. II (1995), McGraw-Hill, New York 2741-2784
25. Merrill Jr. A.H., Schmelz E.M., Wang E., Schroeder J.J., Dillehay D.L., and Riley R.T. Role of dietary sphingolipids and inhibitors of sphingolipid metabolism in cancer and other diseases. J. Nutr. 125 (1995) 1677S-1682S
26. Hannun Y.A. The sphingomylein cycle and the second messenger function of ceramide. J. Biol. Chem. 269 (1994) 3125-3128
27. Kolesnick R., and Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77 (1994) 325-328
28. Merrill Jr. A.H., Liotta D.C., and Riley R.E. Bioactive properties of sphingosine and structurally related compounds. Handbook of Lipid Research 8 (1996) 205-237 R.M. Bell
29. Domon B., Vath J.E., and Costello C.E. Analysis of derivatized ceramides and neutral glycosphingolipids by high-performance tandem mass spectrometry. Anal. Biochem. 184 (1990) 151-164